✦ LIBER ✦

Open label trial of clarithromycin therapy in Japanese patients with Crohn’s disease

✍ Scribed by Satoko Inoue; Hiroshi Nakase; Minoru Matsuura; Satoru Ueno; Norimitsu Uza; Hiroshi Kitamura; Sakae Mikami; Hiroyuki Tamaki; Katsuhiro Kasahara; Tsutomu Chiba

Book ID: 108951010
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 139 KB
Volume: 22
Category: Article
ISSN: 0815-9319
DOI: 10.1111/j.1440-1746.2006.04533.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term results with azathioprine ther

Long-term results with azathioprine therapy in patients with corticosteroid-dependent Crohn’s disease: Open-label prospective study

✍ Julio Maria Fonseca Chebli; Pedro Duarte Gaburri; Aécio Flávio Meirelles De Souz 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

Increased sugar consumption in Japanese

Increased sugar consumption in Japanese patients with Crohn’s disease

✍ Matsui, Toshiyuki ;Iida, Mitsuo ;Fujishima, Masatoshi ;Imai, Katsumi ;Yao, Tsune 📂 Article 📅 1990 🏛 Springer-Verlag 🌐 English ⚖ 77 KB

Clinical trial: randomized study of clar

Clinical trial: randomized study of clarithromycin versus placebo in active Crohn’s disease

✍ K. LEIPER; K. MARTIN; A. ELLIS; A. J. M. WATSON; A. I. MORRIS; J. M. RHODES 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 261 KB

Adalimumab in patients with Crohn’s dise

Adalimumab in patients with Crohn’s disease – safety and efficacy in an open-label single centre study

✍ J. SEIDERER; S. BRAND; J. DAMBACHER; S. PFENNIG; M. JÜRGENS; B. GÖKE; T. OCHSENK 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 538 KB

S-adenosyl-methionine improves depressio

S-adenosyl-methionine improves depression in patients with Parkinson's disease in an open-label clinical trial

✍ Alessandro Di Rocco; John D. Rogers; Richard Brown; Peter Werner; Teodoro Bottig 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 29 KB 👁 2 views

Efficacy of infliximab in pediatric Croh

Efficacy of infliximab in pediatric Crohn's disease: A randomized multicenter open-label trial comparing scheduled to on demand maintenance therapy

✍ Frank M. Ruemmele; Alain Lachaux; Jean-Pierre Cézard; Alain Morali; Chantal Maur 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 2 views

## Background: Infliximab (ifx) is efficacious in inducing remission in severe forms of pediatric crohn's disease (cd). adult studies indicate that ifx is also safe and well tolerated as maintenance therapy. the present study aimed to evaluate in a prospective manner the efficacy and safety of ifx